Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.
2.

Improving the Specificity of PSA Screening with Serum and Urine Markers.

Kearns JT, Lin DW.

Curr Urol Rep. 2018 Aug 13;19(10):80. doi: 10.1007/s11934-018-0828-6. Review.

PMID:
30105509
3.

Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS).

Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW.

J Urol. 2018 Aug 1. pii: S0022-5347(18)43635-X. doi: 10.1016/j.juro.2018.07.065. [Epub ahead of print]

PMID:
30076904
4.

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.

Kearns JT, Holt SK, Wright JL, Lin DW, Lange PH, Gore JL.

Cancer. 2018 Jul 1;124(13):2733-2739. doi: 10.1002/cncr.31337. Epub 2018 May 21.

PMID:
29781117
5.

A longitudinal study of risk factors for suicide attempts among Operation Enduring Freedom and Operation Iraqi Freedom veterans.

Lee DJ, Kearns JC, Wisco BE, Green JD, Gradus JL, Sloan DM, Nock MK, Rosen RC, Keane TM, Marx BP.

Depress Anxiety. 2018 Jul;35(7):609-618. doi: 10.1002/da.22736. Epub 2018 Apr 10.

PMID:
29637667
6.

Indomethacin Enhances Brown Fat Activity.

Hao L, Kearns J, Scott S, Wu D, Kodani SD, Morisseau C, Hammock BD, Sun X, Zhao L, Wang S.

J Pharmacol Exp Ther. 2018 Jun;365(3):467-475. doi: 10.1124/jpet.117.246256. Epub 2018 Mar 22.

PMID:
29567865
7.

Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.

Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y.

Eur Urol. 2018 Aug;74(2):211-217. doi: 10.1016/j.eururo.2018.01.017. Epub 2018 Feb 9.

PMID:
29433975
8.

Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study.

Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW.

Eur Urol. 2018 May;73(5):706-712. doi: 10.1016/j.eururo.2018.01.016. Epub 2018 Feb 9.

PMID:
29433973
9.

Artificial barriers prevent genetic recovery of small isolated populations of a low-mobility freshwater fish.

Coleman RA, Gauffre B, Pavlova A, Beheregaray LB, Kearns J, Lyon J, Sasaki M, Leblois R, Sgro C, Sunnucks P.

Heredity (Edinb). 2018 Jun;120(6):515-532. doi: 10.1038/s41437-017-0008-3. Epub 2018 Jan 12.

10.

Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database.

Winters BR, Kearns JT, Holt SK, Mossanen M, Lin DW, Wright JL.

Urol Oncol. 2018 Mar;36(3):92.e11-92.e16. doi: 10.1016/j.urolonc.2017.11.005. Epub 2017 Nov 27.

PMID:
29174944
11.

Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.

Babushok DV, Duke JL, Xie HM, Stanley N, Atienza J, Perdigones N, Nicholas P, Ferriola D, Li Y, Huang H, Ye W, Morrissette JJD, Kearns J, Porter DL, Podsakoff GM, Eisenlohr LC, Biegel JA, Chou ST, Monos DS, Bessler M, Olson TS.

Blood Adv. 2017 Oct 10;1(22):1900-1910.

12.

Assessing a single targeted next generation sequencing for human leukocyte antigen typing protocol for interoperability, as performed by users with variable experience.

Gandhi MJ, Ferriola D, Lind C, Duke JL, Huynh A, Papazoglou A, Mackiewicz K, Christiansen M, Dong W, Hsu S, Thomas D, Schneider B, Pierce E, Kearns J, Kamoun M, Monos D, Askar M.

Hum Immunol. 2017 Oct;78(10):642-648. doi: 10.1016/j.humimm.2017.07.012. Epub 2017 Jul 18.

PMID:
28732721
13.

Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).

Schoeberl B, Kudla A, Masson K, Kalra A, Curley M, Finn G, Pace E, Harms B, Kim J, Kearns J, Fulgham A, Burenkova O, Grantcharova V, Yarar D, Paragas V, Fitzgerald J, Wainszelbaum M, West K, Mathews S, Nering R, Adiwijaya B, Garcia G, Kubasek B, Moyo V, Czibere A, Nielsen UB, MacBeath G.

NPJ Syst Biol Appl. 2017 Jan 5;3:16034. doi: 10.1038/npjsba.2016.34. eCollection 2017. Review.

14.

Prediction models for prostate cancer outcomes: what is the state of the art in 2017?

Kearns JT, Lin DW.

Curr Opin Urol. 2017 Sep;27(5):469-474. doi: 10.1097/MOU.0000000000000423. Review.

PMID:
28650863
15.

Severe consequences of habitat fragmentation on genetic diversity of an endangered Australian freshwater fish: A call for assisted gene flow.

Pavlova A, Beheregaray LB, Coleman R, Gilligan D, Harrisson KA, Ingram BA, Kearns J, Lamb AM, Lintermans M, Lyon J, Nguyen TTT, Sasaki M, Tonkin Z, Yen JDL, Sunnucks P.

Evol Appl. 2017 May 11;10(6):531-550. doi: 10.1111/eva.12484. eCollection 2017 Jul.

16.

A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan.

Cleary JM, McRee AJ, Shapiro GI, Tolaney SM, O'Neil BH, Kearns JD, Mathews S, Nering R, MacBeath G, Czibere A, Sharma S, Korn WM.

Invest New Drugs. 2017 Feb;35(1):68-78. doi: 10.1007/s10637-016-0399-7. Epub 2016 Nov 16.

PMID:
27853996
17.

Prostate cancer screening: Do guidelines matter?

Kearns JT, Gore JL.

Cancer. 2016 Dec 15;122(24):3760-3761. doi: 10.1002/cncr.30331. Epub 2016 Sep 22. No abstract available.

18.

Environmental Comparison of Biochar and Activated Carbon for Tertiary Wastewater Treatment.

Thompson KA, Shimabuku KK, Kearns JP, Knappe DR, Summers RS, Cook SM.

Environ Sci Technol. 2016 Oct 6. [Epub ahead of print]

PMID:
27656757
19.

Clinical validity and utility of genetic risk scores in prostate cancer.

Helfand BT, Kearns J, Conran C, Xu J.

Asian J Androl. 2016 Jul-Aug;18(4):509-14. doi: 10.4103/1008-682X.182981. Review.

20.

Note: A portable laser induced breakdown spectroscopy instrument for rapid sampling and analysis of silicon-containing aerosols.

McLaughlin RP, Mason GS, Miller AL, Stipe CB, Kearns JD, Prier MW, Rarick JD.

Rev Sci Instrum. 2016 May;87(5):056103. doi: 10.1063/1.4949506.

21.
22.

Biochar sorbents for sulfamethoxazole removal from surface water, stormwater, and wastewater effluent.

Shimabuku KK, Kearns JP, Martinez JE, Mahoney RB, Moreno-Vasquez L, Summers RS.

Water Res. 2016 Jun 1;96:236-45. doi: 10.1016/j.watres.2016.03.049. Epub 2016 Mar 24.

PMID:
27060527
23.

Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease.

Corti D, Kearns JD.

Curr Opin Immunol. 2016 Jun;40:51-61. doi: 10.1016/j.coi.2016.03.001. Epub 2016 Mar 23. Review.

PMID:
26995095
24.

Ninety-day perioperative complications of pediatric robotic urological surgery: A multi-institutional study.

Dangle PP, Akhavan A, Odeleye M, Avery D, Lendvay T, Koh CJ, Elder JS, Noh PH, Bansal D, Schulte M, MacDonald J, Shukla A, Kim C, Herbst K, Corbett S, Kearns J, Kunnavakkam R, Gundeti MS.

J Pediatr Urol. 2016 Apr;12(2):102.e1-6. doi: 10.1016/j.jpurol.2015.08.015. Epub 2015 Oct 9.

PMID:
26897324
25.

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations.

Arena S, Siravegna G, Mussolin B, Kearns JD, Wolf BB, Misale S, Lazzari L, Bertotti A, Trusolino L, Adjei AA, Montagut C, Di Nicolantonio F, Nering R, Bardelli A.

Sci Transl Med. 2016 Feb 3;8(324):324ra14. doi: 10.1126/scitranslmed.aad5640.

26.

The Association Between Masculinity and Nonsuicidal Self-Injury.

Green JD, Kearns JC, Ledoux AM, Addis ME, Marx BP.

Am J Mens Health. 2018 Jan;12(1):30-40. doi: 10.1177/1557988315624508. Epub 2015 Dec 30.

27.

Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.

Frank R, Lal P, Kearns J, Molina MR, Wald JW, Goldberg LR, Kamoun M.

Am J Clin Pathol. 2016 Jan;145(1):62-8. doi: 10.1093/ajcp/aqv016.

PMID:
26712872
28.

An evaluation of the toxicity and bioaccumulation of bismuth in the coastal environment using three species of macroalga.

Kearns J, Turner A.

Environ Pollut. 2016 Jan;208(Pt B):435-41. doi: 10.1016/j.envpol.2015.10.011. Epub 2015 Nov 6.

PMID:
26552530
29.

Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer.

Kearns JT, Lapin B, Wang E, Roehl KA, Cooper P, Catalona WJ, Helfand BT.

Eur Urol. 2016 Feb;69(2):223-8. doi: 10.1016/j.eururo.2015.09.004. Epub 2015 Sep 26.

30.

Fitness to drive in cognitive impairment--a quantitative study of GPs' experience.

Doherty U, Hawke AL, Kearns J, Kelly M.

Ir Med J. 2015 Apr;108(4):112-4.

PMID:
26016301
31.

IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer.

Tsui R, Kearns JD, Lynch C, Vu D, Ngo KA, Basak S, Ghosh G, Hoffmann A.

Nat Commun. 2015 May 7;6:7068. doi: 10.1038/ncomms8068.

32.

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic.

Kearns JD, Bukhalid R, Sevecka M, Tan G, Gerami-Moayed N, Werner SL, Kohli N, Burenkova O, Sloss CM, King AM, Fitzgerald JB, Nielsen UB, Wolf BB.

Mol Cancer Ther. 2015 Jul;14(7):1625-36. doi: 10.1158/1535-7163.MCT-14-0772. Epub 2015 Apr 24.

33.

Bulk fill restoratives: to cap or not to cap--that is the question?

Tomaszewska IM, Kearns JO, Ilie N, Fleming GJ.

J Dent. 2015 Mar;43(3):309-16. doi: 10.1016/j.jdent.2015.01.010. Epub 2015 Jan 24.

PMID:
25625673
34.

Transplant nephrectomy: histologic findings—a single center study.

Goral S, Brukamp K, Ticehurst EH, Abt PL, Bloom RD, Kearns J, Constantinescu S, Kamoun M, Tomaszewski J.

Am J Nephrol. 2014;40(5):491-8. doi: 10.1159/000369865. Epub 2014 Dec 9.

PMID:
25504182
35.

Pediatric robotic urologic surgery-2014.

Kearns JT, Gundeti MS.

J Indian Assoc Pediatr Surg. 2014 Jul;19(3):123-8. doi: 10.4103/0971-9261.136456. Review.

36.

Cuspal deflection and cervical microleakage scores to determine the adhesive potential of universal bonding systems.

Kearns JO, Barry JG, Fleming GJ.

J Dent. 2014 Aug;42(8):970-6. doi: 10.1016/j.jdent.2014.05.013. Epub 2014 Jun 3.

PMID:
24943379
37.

2,4-D adsorption to biochars: effect of preparation conditions on equilibrium adsorption capacity and comparison with commercial activated carbon literature data.

Kearns JP, Wellborn LS, Summers RS, Knappe DR.

Water Res. 2014 Oct 1;62:20-8. doi: 10.1016/j.watres.2014.05.023. Epub 2014 Jun 2.

PMID:
24934321
38.

Biochar as a sustainable electrode material for electricity production in microbial fuel cells.

Huggins T, Wang H, Kearns J, Jenkins P, Ren ZJ.

Bioresour Technol. 2014 Apr;157:114-9. doi: 10.1016/j.biortech.2014.01.058. Epub 2014 Jan 24.

PMID:
24534792
39.

Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome.

Contreras-Ruiz L, Regenfuss B, Mir FA, Kearns J, Masli S.

PLoS One. 2013 Sep 23;8(9):e75937. doi: 10.1371/journal.pone.0075937. eCollection 2013.

40.

Urodynamic studies in spinal cord tethering.

Kearns JT, Esposito D, Dooley B, Frim D, Gundeti MS.

Childs Nerv Syst. 2013 Sep;29(9):1589-600. doi: 10.1007/s00381-013-2136-2. Epub 2013 Sep 7. Review.

PMID:
24013329
41.

Outcomes of infants undergoing robot-assisted laparoscopic pyeloplasty compared to open repair.

Dangle PP, Kearns J, Anderson B, Gundeti MS.

J Urol. 2013 Dec;190(6):2221-6. doi: 10.1016/j.juro.2013.07.063. Epub 2013 Aug 1.

PMID:
23911637
42.

Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies.

Harms BD, Kearns JD, Iadevaia S, Lugovskoy AA.

Methods. 2014 Jan 1;65(1):95-104. doi: 10.1016/j.ymeth.2013.07.017. Epub 2013 Jul 18.

PMID:
23872324
43.

Dual delayed feedback provides sensitivity and robustness to the NF-κB signaling module.

Longo DM, Selimkhanov J, Kearns JD, Hasty J, Hoffmann A, Tsimring LS.

PLoS Comput Biol. 2013;9(6):e1003112. doi: 10.1371/journal.pcbi.1003112. Epub 2013 Jun 27.

44.

Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.

Shih VF, Davis-Turak J, Macal M, Huang JQ, Ponomarenko J, Kearns JD, Yu T, Fagerlund R, Asagiri M, Zuniga EI, Hoffmann A.

Nat Immunol. 2012 Dec;13(12):1162-70. doi: 10.1038/ni.2446. Epub 2012 Oct 21.

45.

Group diabetes education administered through telemedicine: tools used and lessons learned.

Kearns JW, Bowerman D, Kemmis K, Izquierdo RE, Wade M, Weinstock RS.

Telemed J E Health. 2012 Jun;18(5):347-53. doi: 10.1089/tmj.2011.0165. Epub 2012 Apr 2.

PMID:
22468984
46.

Optimizing properties of antireceptor antibodies using kinetic computational models and experiments.

Harms BD, Kearns JD, Su SV, Kohli N, Nielsen UB, Schoeberl B.

Methods Enzymol. 2012;502:67-87. doi: 10.1016/B978-0-12-416039-2.00004-5.

PMID:
22208982
47.

Comparison of distal ureteral management strategies during laparoscopic nephroureterectomy.

Ritch CR, Kearns JT, Mues AC, Hruby GW, Benson MC, McKiernan JM, Landman J.

J Endourol. 2011 Jul;25(7):1149-54. doi: 10.1089/end.2010.0542. Epub 2011 Jun 20.

PMID:
21689004
48.

Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues.

Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ.

Neurology. 2011 Jun 14;76(24):2089-95. doi: 10.1212/WNL.0b013e31821f468f. Review.

PMID:
21670438
49.

Refractory absence epilepsy associated with GLUT-1 deficiency syndrome.

Byrne S, Kearns J, Carolan R, Mc Menamin J, Klepper J, Webb D.

Epilepsia. 2011 May;52(5):1021-4. doi: 10.1111/j.1528-1167.2011.02989.x. Epub 2011 Mar 2.

50.

Polymorphisms in the TNF-α and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects.

Banerjee N, Nandy S, Kearns JK, Bandyopadhyay AK, Das JK, Majumder P, Basu S, Banerjee S, Sau TJ, States JC, Giri AK.

Toxicol Sci. 2011 May;121(1):132-9. doi: 10.1093/toxsci/kfr046. Epub 2011 Feb 25.

Supplemental Content

Loading ...
Support Center